Trade Bristol Myers ^BMY

4 Healthcare Dividend Stocks for Retirees. One Yields Over 4%

Schrodinger Eyes Growth From AI Assistant Bunsen and Hosted Software Shift - Stock Observer

A Record-High Dividend Yield Can Be a Warning Sign. Just Ask Pfizer

Have Insiders Sold Bristol-Myers Squibb Shares Recently?

FY2026 EPS Forecast for Bristol Myers Squibb Cut by Analyst

Bristol Myers Squibb Company $BMY Stock Bought by PBU The Pension Fund of Early Childhood & Youth Educators - Zolmax

Eurizon Capital SGR S.p.A. Sells 240,580 Shares of Bristol Myers Squibb Company $BMY - Zolmax

Bristol Myers Squibb Company $BMY Stock: Eurizon Capital SGR S.p.A. Cuts Stake - Daily Political

Bristol Myers Squibb (BMY) Stock Looks Below Fair Value Following A 41% Run

Bristol Myers research chief to depart in 'evolution' of company's structure

Bristol Myers to Unite R&D Organization Under Cristian Massacesi | Morningstar

Bristol Myers to merge scientific, clinical teams under new R&D structure - Yahoo News Malaysia

Bristol Myers Squibb Company $BMY Stock Holdings Increased by King Luther Capital Management Corp - Stock Observer

Bristol Myers Squibb Company $BMY Position Cut by Keybank National Association OH - Daily Political

Effect of two common GVHD prophylaxis regimens on the gut microbiome in a randomized phase 3 trial

Americans Fill Prescriptions Every Month, and $90,000 Across These 3 Drugmakers Pays $3,650 a Year

Bristol Myers Squibb (NYSE:BMY) Share Price Crosses Above 50-Day Moving Average - Here's Why

Normalized membrane ratio of TROP2 as a predictor of clinical outcomes with datopotamab deruxtecan in non-small-cell lung cancer

Bristol Myers Squibb Company $BMY Shares Bought by Allspring Global Investments Holdings LLC

Bristol Myers Squibb Company $BMY Stake Trimmed by M&G PLC - Stock Observer

Bristol Myers Squibb (BMY), What Is Behind Its Latest Update?

5 Defensive Dividend Stocks Yielding Up to 8.7% for Retirement Income

M Holdings Securities Inc. Buys 45,082 Shares of Bristol Myers Squibb Company $BMY

BMS's Camzyos shows continued benefit in paediatric oHCM at 56 weeks

The Leukemia Therapeutics Market is estimated to reach USD 31.43 billion by 2034, witnessing a CAGR of 6.6% throughout the forecast period.

Bristol Myers Squibb Company $BMY Stock Sold by CenterBook Partners LP

Bristol Myers Squibb Company $BMY Shares Bought by Pictet Asset Management Holding SA - Stock Observer

Does Growth Drug Sales Change The Bull Case For Bristol Myers Squibb Stock?

Bristol Myers Squibb Company $BMY Stock: Kestra Advisory Services LLC Raises Position - Daily Political

An ulcerative colitis taxonomy defined by individual patient-reported response trajectories

Bristol Myers Squibb Company $BMY Position Lifted by Avantax Planning Partners Inc.

Bristol Myers Squibb Company $BMY Shares Purchased by Avantax Planning Partners Inc.

Bristol Myers Squibb Company $BMY Holdings Lifted by Ethic Inc.

22,500 Bristol Myers Squibb Company $BMY Shares Sold by Axiom Investment Management LLC

Bristol Myers Squibb Company $BMY Shares Sold by Commonwealth Equity Services LLC

Analyzing Prothena (NASDAQ:PRTA) & Century Therapeutics (NASDAQ:IPSC) - Markets Daily

Bristol Myers Squibb Company $BMY Stock Purchased by Candriam S.C.A. - Daily Political

Bristol Myers Squibb Company $BMY Stake Cut by United Advisor Group LLC - Daily Political

Bristol Myers Squibb Company $BMY Stock Bought by Alps Advisors Inc.

Has Bristol-Myers Squibb (BMY) Moved Above Fair Value After A 41% Gain?

Bristol Myers Squibb (NYSE:BMY) Director Julia Haller Sells 3,800 Shares of Company Stock

Bristol Myers Squibb Yields Over 4%. Can Its Dividend Survive 2027?

Bristol Myers Squibb (NYSE:BMY) Director Sells $240,578.00 in Stock - Stock Observer

Critical Analysis: Bristol Myers Squibb (BMY) versus Its Competitors

What Halozyme Therapeutics (HALO) Said on Its Q3 Earnings Call

Bristol Myers Squibb Company $BMY Stock: Pzena Investment Management LLC Lowers Holdings

Bristol Myers Squibb Company $BMY Shares Sold by AIA Group Ltd

48,234 Shares in Bristol Myers Squibb Company $BMY Acquired by Associated Banc Corp

An information-theoretic framework for inferring T cell dynamics from single-cell RNA and T cell receptor sequencing

Bristol Myers Squibb Canada Partners with TANK Worldwide and Ogilvy Health to Turn Autumn Leaves into a Guide for Spotting the Warning Signs of Melanoma

Head-To-Head Contrast: Bristol Myers Squibb (BMY) & Its Peers - Zolmax

Bristol Myers Squibb Company $BMY Stock Holdings Raised by Rakuten Investment Management Inc.

Bristol Myers Squibb Shares Rose Even As Profit Fell

Bausch Health Cos (NYSE:BHC) & Bristol Myers Squibb (NYSE:BMY) Head-To-Head Comparison - Markets Daily

Analyzing Bristol Myers Squibb (NYSE:BMY) and Bausch Health Cos (NYSE:BHC) - Stock Observer

Why Tempus AI Stock Is Up 8.7% And What's Next

Bristol Myers Squibb Company $BMY Shares Newly Purchased by VCI Wealth Management LLC

Bristol Myers Squibb (NYSE:BMY) Stock Price Breaks Above 50 Day Moving Average on Analyst Downgrade - Stock Observer

Reply to: 'Interpreting surgical consolidation in oligometastatic gastro-oesophageal cancer'

Regulatable membrane-bound IL-15 engineered TIL cell therapy for immune checkpoint inhibitor-resistant advanced melanoma: pooled analysis of phase 1 and 1/2 trials

5 must-read analyst questions from Bristol-Myers Squibb's Q3 earnings call

TEM Stock Jumps On Upbeat Revenue, Raised Outlook - Cathie Wood's ARK Buys Over 154K Shares Ahead Of Earnings

43 ETFs Add to Bristol-Myers Squibb (BMY) on Oct. 29

Bank Julius Baer & Co. Ltd Zurich Purchases 73,200 Shares of Bristol Myers Squibb Company $BMY

18,717 Bristol Myers Squibb Company $BMY Shares Purchased by Profund Advisors LLC - Stock Observer

Bristol Myers Squibb (NYSE:BMY) Stock Gets Price Target Trim from Morgan Stanley - Zolmax

Bristol Myers Squibb Company $BMY Stock: Heritage Investors Management Corp Cuts Position - Daily Political

Learn Why The Bull Case For Bristol Myers Squibb Stock Could Change Following Earnings Beat

Molecular and immune heterogeneity across limited-stage and extensive-stage small cell lung cancer

Denosumab in multiple myeloma patients with severe renal impairment: a multicenter phase 2 study

Povorcitinib for nonsegmental vitiligo: two randomized, controlled, phase 3 STOP-V trials

Mirae Asset Global Investments Co. Ltd. Makes New Investment in Bristol Myers Squibb Company $BMY

Sumitomo Mitsui Trust Group Inc. Sells 19,128 Shares of Bristol Myers Squibb Company $BMY - Daily Political

Hengrui's third-quarter profit rebounds on out-licensing revenue

Why Everyone Is Watching Bristol-Myers Squibb (BMY) Today

What Bristol Myers Squibb Stock's Earnings Beat Means For Shareholders

Bristol Myers Squibb Company $BMY Stock Bought by Americana Partners LLC - Markets Daily

Bristol Myers Squibb Company $BMY Shares Sold by VIRGINIA RETIREMENT SYSTEMS ET Al

Birinyi Associates Inc. Purchases New Position in Bristol Myers Squibb Company $BMY

Americana Partners LLC Acquires 46,008 Shares of Bristol Myers Squibb Company $BMY - Stock Observer

Bristol Myers Squibb Company $BMY Stock Sold by VIRGINIA RETIREMENT SYSTEMS ET Al - Stock Observer

Bristol Myers Squibb (NYSE:BMY) Stock Price Target Cut by Morgan Stanley - Stock Observer

Is Bristol-Myers Squibb (BMY) Stock Cheap, Or Are Risks Priced In?

Bristol Myers Squibb Q3 Earnings Call Highlights

Head and Neck Squamous Cell Carcinoma Market Size in the 7MM is projected to reach nearly USD 2,560 million by 2036, growing at a CAGR of 10.5% during 2026-2036 | DelveInsight | ABNewswire

Neuroendocrine Prostate Cancer Market and Pipeline Appear Robust With Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight | ABNewswire

Bristol Myers Squibb (NYSE:BMY) Posts Earnings Results, Beats Expectations By $0.25 EPS